Keywords: APC; antigen presenting cell; APOBEC; apolipoprotein B mRNA editing enzyme catalytic polypeptide-like; BRCA1/2; breast cancer 1/2; BCSS; breast cancer specific survival; B2M; β-2-microglobulin; CAF; cancer associated fibroblast; CCL; chemokine ligand; CD
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ADP; adenosine diphosphate; ANT; adenine nucleotide translocator; ATP; adenosine triphosphate; Bax; BCL2-associated X protein; Bcl-xL; B-cell lymphoma-extra large; CLP; cecal ligation and puncture; CyP; cyclophilin; DAMP; damage-associated molecular patte
Keywords: AP-1; activator protein 1; APC; antigen-presenting cells; ARE; AU-rich element; ASK; Apoptosis Signal regulating Kinase; ATF-2; Activating Transcription Factor 2; CRE; Cyclic AMP Responsive Element; CBP; CREB binding protein; CsA; ciclosporin A; ERK; Extr
Keywords: APC; adenomatous polyposis coli; bFGF; basic fibroblast growth factor; Ca2Â +i; intracellular calcium; Ca2Â +o; extracellular calcium; CaSR; calcium sensing receptor; CDX-2; caudal type homeobox 2; EGF; epidermal growth factor; ERK; extracellular-signal-r
Keywords: Abl; Abelson leukemia proto-oncogene; ADAP; adhesion and degranulation promoting adapter protein (Fyb, SLAP-130); Asc; apoptosis-associated speck-like protein containing a CARD; BCR; B-cell receptor; C3G; Crk SH3 domain-binding guanine nucleotide exchange
Androgen receptor (AR) degradation enhancer ASC-J9® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth
Keywords: Androgen receptor; Prostate cancer; Prostate therapy; ASC-J9®; IC50; Epithelial cells; Stromal cells; Fibroblasts; Myofibroblasts; Apoptosis; FDA-approved formula; AR; androgen receptor; PCa; prostate cancer; RT-PCR; reverse transcription polymerase chai
ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway
Keywords: Akt; oncogene in the transforming retrovirus, AKT8; AP-1; activator protein 1; ARAF; v-raf murine sarcoma 3611 viral oncogene homologue; ASK1; apoptosis signal-regulating kinase 1; BCL2; B-cell lymphoma 2; BCL-XL; B-cell lymphoma extra large; BRAF; v-raf
Pervanadate induces Mammalian Ste20 Kinase 3 (MST3) tyrosine phosphorylation but not activation
Keywords: Cys; cysteine; DMEM; Dulbecco's modified Eagle's medium; EGFR; epidermal growth factor receptor; GPCR; G protein-coupled receptor; HEK 293; human embryonic kidney 293; HPK1; hematopoietic progenitor kinase 1; MST; mammalian Ste20 kinase; MAP4K; MAP kinase
Fgf regulates dedifferentiation during skeletal muscle regeneration in adult zebrafish
Keywords: EdU; 5-ethynyl-2â²-deoxyuridine; EOM; extraocular muscle; hpi; hours post injury; dpi; days post injury; Fgf; fibroblast growth factor; Fgfr; fibroblast growth factor receptor; LR; lateral rectus; Tc; cell cycle length; Ts; length of S-phase; MAPK; mitog
The p21-activated kinase, PAK2, is important in the activation of numerous pancreatic acinar cell signaling cascades and in the onset of early pancreatitis events
Keywords: CCK; COOH-terminal octapeptide of cholecystokinin; TPA; 12-O-tetradecanoylphorbol-13-acetate; PAK; p21-activated kinases; SFK; Src family of kinases; PKC; protein kinase C; PYK2; proline-rich tyrosine kinase 2; FAK; focal adhesion kinase; SHC; Src homolog
Myrsine seguinii ethanolic extract and its active component quercetin inhibit macrophage activation and peritonitis induced by LPS by targeting to Syk/Src/IRAK-1
Keywords: Ms-EE; ethanolic extract of Myrsine seguinii; PGE2; prostaglandin E2; NO; nitric oxide; COX; cyclooxygenase; iNOS; inducible NO synthase; (TNF)-α; tumour necrosis factor; ERK; extracellular signal-related kinase; TLR; toll-like receptors (TLR); MAPK; mit
Identification of conserved and novel microRNAs in Manduca sexta and their possible roles in the expression regulation of immunity-related genes
Keywords: Posttranscriptional regulation; Illumina sequencing; Lepidoptera; Insect immunity; Target site prediction; Alk; anaplastic lymphoma kinase; AMP; antimicrobial peptides; ANKRD54; ankyrin repeat domain 54; Aop; anterior open; aPKC; atypical protein kinase C
Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains
Keywords: GPCR; G protein-coupled receptor; JNK; c-Jun NH2-terminal protein kinase; MAPK; mitogen-activated protein kinase; MKK or MAPKK; MAP kinase kinase; MAPKKK; MAP kinase kinase kinase; ASK1; Apoptosis signal-regulating kinase 1, a.k.a. mitogen-activated prote
Research ReportDelayed administration of the nucleic acid analog 2Cl-C.OXT-A attenuates brain damage and enhances functional recovery after ischemic stroke
Keywords: COA-Cl; 2Cl-C.OXT-A; ERK; extracellular signal-regulated kinase; LDH; lactate dehydrogenase; MAPK; mitogen-activated protein kinase; MCAO; middle cerebral artery occlusion; MEK; MAP kinase kinase; OGD; oxygen-glucose deprivation; rCBF; regional cerebral b
E-type prostanoid receptor 4 (EP4) in disease and therapy
Keywords: AMPK; AMP-activated protein kinase; cAMP; cyclic adenylyl monophosphate; CFTR; cystic fibrosis transmembrane conductance regulator; ClC; chloride channel; COX; cyclooxygenase; CREB; cAMP-response element-binding protein; DP; D-type prostanoid receptor; DS
Crystal and solution structures disclose a putative transient state of mitogen-activated protein kinase kinase 4
Keywords: JNK; c-Jun NH2-terminal kinase; MAP; mitogen-activated protein; MAP2K; MAP kinase kinase; MAP3K; MAP kinase kinase kinase; npMAP2K4; non-phosphorylated MAP2K4; IPTG; isopropyl-β-d-thiogalactopyranoside; ANP; adenylyl-imidodiphosphate; ATP; adenosine trip
A continuous spectrophotometric assay for mitogen-activated protein kinase kinases
Keywords: Phosphorylation; Dephosphorylation; MAP kinase; MAP kinase kinase; MAP kinase phosphatase
MicroRNA 497 modulates interleukin 1 signalling via the MAPK/ERK pathway
Keywords: IL; interleukin; MAPK; mitogen-activated protein kinase; NFκB; nuclear factor κB; AP-1; jun proto-oncogene; ERK; extracellular signal-regulated kinase; JNK; c-Jun amino-terminal kinase; P38; mitogen-activated protein kinase 14; MEK; MAP Kinase kinase; R
Redox signaling loops in the unfolded protein response
Keywords: AGR2; anterior gradient 2; ARE; antioxidant responsive element; ATF4; activating transcription factor-4; ATF6; activating transcription factor-6; ASK1; apoptosis signal-regulating kinase-1; BI-1; BAX inhibitor-1; BiP; immunoglobulin heavy chain-binding pr
Methanol extract of Osbeckia stellata suppresses lipopolysaccharide- and HCl/ethanol-induced inflammatory responses by inhibiting Src/Syk and IRAK1
Keywords: Os-ME; methanol extract of Osbeckia stellata; PGE2; prostaglandin E2; NO; nitric oxide; COX; cyclooxygenase; iNOS; inducible NO synthase; TNF-α; tumor necrosis factor-alpha; ERK; extracellular signal-related kinase; TLR; toll-like receptor; MAPK; mitogen
Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease
Keywords: AD; Alzheimer's disease; AKT; protein kinase B; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor; aPKC; atypical protein kinase C; APP; amyloid-β precursor protein; ATG; AuTophaGy-related; BDNF; brain-derived neurotrophic factor; C/EBP; C
Trypanosoma brucei: Two mitogen activated protein kinase kinases are dispensable for growth and virulence of the bloodstream form
Keywords: Trypanosoma; Protein kinase; MAP kinase kinase; Gene knockout; Virulence; Stress;
Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry
Keywords: Bcl-xL; B-cell leukemia-xL; CDDP; cis-diammine-dichloro-platinum; DETANONOate; (Z)-1-[2-(2-aminoethyl)-N-(2-ammonio-ethyl) amino] diazen-1-ium-1, 2-diolate; DHMEQ; dehydroxymethylepoxyquinomicin; DR; death receptor; ERK; extracellular signal-regulated kin
Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders
Keywords: Apoptosis; Brain-derived neurotrophic factor (BDNF); Glycogen synthase kinase 3 (GSK-3); Lithium; Neurodegenerative diseases; Neuroprotection; 3-NP; 3-nitropropionic acid; Aβ; β-amyloid; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; AP-1;
The role of protein synthesis in cell cycling and cancer
Keywords: Cell cycle; Elongation factor 2; Elongation factor 2 kinase; Apoptosis; Cancer; AMPK; AMP-activated Kinase; cAMP; cyclic AMP; PKA; Protein Kinase A; FLIP; FLICE-Like Inhibitor Protein; XIAP; X-linked Inhibitor of Apoptosis; EF2; Elongation Factor 2; cdc2/
The Gα4 G protein subunit interacts with the MAP kinase ERK2 using a D-motif that regulates developmental morphogenesis in Dictyostelium
Keywords: PCR; polymerase chain reaction; MAP kinase; mitogen-activated protein kinase; MAPKK; MAP kinase kinase; ERK; extracellular signal-regulated kinase; CD; common docking site; D-motif; MAPK docking site; SDS; sodium dodecyl sulfate; cAMP; cyclic adenosine mo
AP1 binding site is another target of FGF2 regulation of bone sialoprotein gene transcription
Keywords: BSP; bone sialoprotein; FGF2; fibroblast growth factor 2; FRE; FGF response element; bp; base pair(s); nts; nucleotides; PKC; protein kinase C; PKA; cAMP dependent protein kinase; MAP kinase; mitogen activated protein kinase; MEK; MAP kinase kinase; Pit-1
A mutation in the Arabidopsis MAP kinase kinase 9 gene results in enhanced seedling stress tolerance
Keywords: MAP kinase; MAP kinase kinase; Abscisic acid; Salt
Investigation of cell cycle arrest effects of actinomycin D at G1 phase using proteomic methods in B104-1-1 cells
Keywords: AMD; actinomycin D; Hsp; heat shock protein; hTM; human tropomyosin; MEK; MAP kinase kinase; Actinomycin; Proteomics; Cell cycle; MEKK3; Hsp70;
Nuclear phospholipase C-β1b activation during G2/M and late G1 phase in nocodazole-synchronized HL-60 cells
Keywords: PLC; phospholipase C; PtdIns(4,5)P2; phosphatidylinositol 4,5-bisphosphate; DAG; diacylglycerol; Ins(1,4,5)P3; inositol(1,4,5)P3; PKC; protein kinase C; PI3K; phosphatidylinositol 3-kinase; MAPK; mitogen-activated protein kinase; MEK; MAP kinase kinase; P
MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits
Keywords: ARE; AU-rich element; ASK; Apoptosis Signal regulating Kinase; ATF-2; Activating Transcription Factor 2; CRE; Cyclic AMP Responsive Element; ERK; Extracellular signal regulated kinase; iNOS; inducible Nitric Oxide Synthase; JNK; c-Jun N-terminal Kinase; L
N-methyl-d-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: A revolving neurochemical axis for therapeutic intervention?
Keywords: AA; arachidonic acid; AIDS; acquired immunodeficiency syndrome; ALS; amyotrophic lateral sclerosis; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; APV; 2-amino-5-phosphonovalerate; 2-AP5; 2-amino-5-phosphonopentanoic acid; ATF; activating tr
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies
Keywords: Abl; Abelson murine leukemia viral oncogene; AGTR; angiotensin II receptor; Arf; Archaeal Rieske-type ferredoxin; Arp; actin-related protein; BCL2; B-cell CLL/lymphoma 2; BID; BH3 interacting domain death agonist; cMET; receptor for hepatocyte growth fact